The Treatment of Deep Vein Thrombosis Immediately After Kidney Transplantation: A Case Report

Department of Surgery, Seoul St Mary's Hospital, The Catholic University of Korea, College of Medicine, Seoul, Korea.
Transplantation Proceedings (Impact Factor: 0.98). 07/2011; 43(6):2415-7. DOI: 10.1016/j.transproceed.2011.05.041
Source: PubMed


Ipsilateral acute iliofemoral deep vein thrombosis (DVT) immediately after kidney transplantation is rare but highly morbid, resulting in allograft failure, rupture, or even death. Treatment modalities for iliofemoral DVT occurring just after transplantation are limited due to bleeding risk and impaired renal function. A 55-year-old woman with end-stage renal disease from hypertension underwent a living nonrelated donor procedure using a kidney from her husband. On postoperative day 1, the patient presented edema and pain in the right lower extremity associated with local heat and redness. The symptoms became aggravated with time. Duplex ultrasonography (US) revealed a DVT involving from the right femoral vein to the common iliac vein and an increased resistive index of 0.96 to 0.97. A venogram using carbon dioxide as the contrast medium showed also same findings as the duplex US. After inferior vena cava filter insertion, percutaneous transluminal thromboaspiration (PTA) was performed with complete removal of the thrombus. Early PTA with carbon dioxide as intravenous contrast material seemed to be an effective and safe procedure to treat this complication.

12 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study investigated the bactericidal effect of ethanol/water (70:30 vol:vol) against plastic-adherent organisms that commonly cause line infections. The experiments were performed in polycarbonate wells and all incubations were at 37 degrees C. Bacteria in broth were inoculated into wells and incubated (16, 40 and 72 h) before washing to remove non-adherent organisms and exposure to ethanol/water. Wells were then re-incubated with broth to detect surviving bacteria. All organisms incubated for 16 h were killed by 1h of exposure to 70% ethanol. After incubation for 40 h, 4h of exposure to ethanol was required to kill two strains of Candida albicans. Likewise, one of three of both Klebsiella pneumoniae and Pseudomonas aeruginosa, incubated for 72 h, showed growth after 1h of exposure to 70% ethanol but not after 4h of exposure. These results suggest that in contrast to log phase organisms, which are killed by ethanol/water solutions in seconds, plastic-adherent organisms are more resistant to the bactericidal activity of ethanol.
    Journal of Hospital Infection 07/2006; 63(2):193-6. DOI:10.1016/j.jhin.2006.01.009 · 2.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A multidisciplinary intestinal rehabilitation team has been in place at our institution for 3 years. Our goal was to compare the preliminary outcomes of neonates with short bowel syndrome before with those after the establishment of our formalized intestinal failure program (Group for the Improvement of Intestinal Function and Treatment [GIFT]). We conducted a retrospective analysis of our intestinal failure registry comparing preGIFT (1997-1999) with GIFT (2003-2005) outcomes. Fifty-four patients (mean gestational age = 33.5 weeks) were included in the GIFT cohort, and 40 patients (mean gestational age = 30.7 weeks) formed the preGIFT cohort. Overall mortality rates (33.3% vs 37.5%, P = .84) were equivalent in the 2 cohorts, although fewer patients died of liver failure after the establishment of the GIFT. Among those with liver failure, the mortality in the preGIFT group was 9/10 as compared with that of 6/13 in the GIFT group (P = .03). The decrease in liver-related deaths was partly attributable to earlier referral for and increased survival to transplant (4 for the GIFT group vs 0 for the preGIFT group). Analysis of the preliminary outcomes of the GIFT program suggests that the natural history of neonatal short bowel syndrome remains unaltered to date despite a coordinated approach to care. However, improved communication and integration with the transplant service have resulted in earlier assessment, increased rates of transplantation, and decreased mortality from liver failure.
    Journal of Pediatric Surgery 06/2007; 42(5):806-11. DOI:10.1016/j.jpedsurg.2006.12.033 · 1.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to prospectively evaluate the use of intraluminal ethanol for the prevention of catheter-associated bloodstream infection (CABSI) in immunosuppressed haematology patients. Patients receiving chemotherapy for haematological malignancy or haematopoietic cell transplantation were randomized in a double-blinded manner to receive either intraluminal 70% ethanol/water or heparinized saline locks on a daily basis throughout a prophylactic treatment period. The primary endpoint was an episode of CABSI (defined as 'bacteraemia in a febrile patient with a central venous catheter that was in use within the preceding 48 h and with no other identified focus of infection'). The trial was registered with the Australian Clinical Trials Register: number ACTRN012605000383662. There were 34 and 30 prophylactic treatment periods in the ethanol and control groups, respectively. CABSI occurred in 3 (9%, 0.60/100 catheter-days) and 11 (37%, 3.11/100 catheter-days) prophylactic treatment periods in the ethanol and control groups, respectively (OR = 0.18, 95% CI 0.05-0.65, P = 0.008). Eleven (32%) and 5 (17%) patients in the ethanol and control groups, respectively, remained afebrile throughout the prophylactic treatment (P = 0.18). The daily administration of ethanol locks into lumens of central venous catheters effectively reduces the incidence of CABSI.
    Journal of Antimicrobial Chemotherapy 08/2008; 62(4):809-15. DOI:10.1093/jac/dkn284 · 5.31 Impact Factor
Show more